Current strategies in cancer gene therapy

This publication has 80 references indexed in Scilit:

• Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β₂‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors
  Tissue Antigens, 2003
• Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene
  Experimental Cell Research, 2003
• The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma
  British Journal of Plastic Surgery, 2002
• Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
  Current Gene Therapy, 2001
• Gene Therapy of Orthotopic Hepatocellular Carcinoma in Rats Using Adenovirus Coding for Interleukin 12
  Hepatology, 2001
• The molecular biology of cancer
  Molecular Aspects of Medicine, 2000
• Liver Damage using Suicide Genes: A Model for Oval Cell Activation
  The American Journal of Pathology, 2000
• A triploblast origin for Myxozoa?
  Nature, 1998
• Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.
  Proceedings of the National Academy of Sciences, 1996
• T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years
  Science, 1995